Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The clinical trial record is displayed with its study status, eligibility criteria, treatment arms, outcome measures, and related documents.
    Difference
    54%
    Check dated 2026-11-11T01:39:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:51:54.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unchanged 403 error page. The site revision number also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:57:04.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:11:45.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, making the content inaccessible; the previous study details are replaced by the error message with a Home link available.
    Difference
    19%
    Check dated 2026-09-23T01:06:15.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous v3.6.6, indicating an internal update to the site’s versioning rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-09-16T00:12:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.